The U.S. Army Medical Research Acquisition Activity (USAMRAA) awarded a $11,959.20 Firm Fixed Price purchase order contract to Synbio Technologies LLC, a minority-owned small business, to provide a synthetic plasmid containing the AP50c phage genome modified with an eGFP tag. This sole-source contract was issued under the authority of Federal Acquisition Regulation (FAR) 13.106(b)(1) on behalf of the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID). The plasmid must be able to maintain stability with a 14kb genome insert and be capable of expression in E. coli. This requirement was set aside for small business participation.
Generated 7/29/24, 9:17 AM